✦ LIBER ✦

The challenge of indication extrapolation for infliximab biosimilars

✍ Scribed by Feagan, Brian G.; Choquette, Denis; Ghosh, Subrata; Gladman, Dafna D.; Ho, Vincent; Meibohm, Bernd; Zou, Guangyong; Xu, Zhenhua; Shankar, Gopi; Sealey, David C.; Russell, Anthony S.

Book ID: 125794943
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 283 KB
Volume: 42
Category: Article
ISSN: 1045-1056
DOI: 10.1016/j.biologicals.2014.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biosimilars: In support of extrapolation

✍ Ebbers, Hans C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 231 KB

Is Extrapolation of the Safety and Effic

Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

✍ Lee, Howard 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 187 KB

The challenge of biosimilars

✍ Mellstedt, H.; Niederwieser, D.; Ludwig, H. 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 325 KB

Infliximab approved for new indication i

Infliximab approved for new indication in Japan

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Biosimilars to treat inflammatory arthri

✍ Kay, J.; Smolen, J. S. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 240 KB

Biosimilar Medicines—New Challenges for

✍ Fox, Andrew 📂 Article 📅 2009 🏛 Taylor and Francis Group 🌐 English ⚖ 142 KB